drugset / Trial / NCT03846258

High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy

NCT03846258 ↗

Phase 4 Withdrawn Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

Researchers are trying to determine which dialysis solution, low bicarbonate fluid (22 mmol/L) or high bicarbonate fluid (32 mmol/L), is better in subjects with acute kidney injury (acute kidney failure) and metabolic acidosis that are admitted to the intensive care unit and require continuous renal replacement therapy (also known as continuous dialysis).

Timeline

Start
2019-05-01
Primary completion
2024-04-01
Completion
2024-04-01

Outcome

Outcome not reported

Stopped: “Due to the fact that we were unable to find subjects who met all inclusion and exclusion criteria it was determined to withdraw this study.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phoxillum Unknown 22 unknown —
Comparator Prismasate Unknown 32 unknown —